Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Artificial Cells Nanomedicine and Biotechnology

• Publication date

  2017-07-04

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1080/21691401.2016.1196457PMID 27327352
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer.

  2015cited by this paper
• A simple and rapid method for detection of paraquat in human plasma by high-performance liquid chromatography.

  2015cited by this paper
• Design, optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer

  2015cited by this paper
• Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect

  2015cited by this paper
• Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy

  2014influential reference
• Insight into nanoparticle cellular uptake and intracellular targeting.

  2014cited by this paper
• Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging.

  2013cited by this paper
• Solid Dispersions as Strategy to Improve Oral Bioavailability of Poor Water Soluble Drugs

  2013cited by this paper
• The Effect of PEG Molecular Weights on Dissolution Behavior of Simvastatin in Solid Dispersions

  2013cited by this paper
• Inecalcitol, an analog of 1α,25(OH)2D3, induces growth arrest of androgen‐dependent prostate cancer cells

  2012cited by this paper
• A review on comb-shaped amphiphilic polymers for hydrophobic drug solubilization.

  2012cited by this paper
• Synthesis and Characterization of Poly(D,L-Lactide-co-Glycolide) Copolymer

  2012cited by this paper
• Formation of bicalutamide nanodispersion for dissolution rate enhancement.

  2011cited by this paper
• Enhancement of Dissolution Rate of Indomethacin: Using Liquisolid Compacts

  2011cited by this paper
• Kinetic modeling on drug release from controlled drug delivery systems.

  2010cited by this paper
• Cyclosporin A Loaded PLGA Nanoparticle: Preparation, Optimization, In-Vitro Characterization and Stability Studies

  2010cited by this paper
• Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation

  2010cited by this paper
• Dendrimers as versatile platform in drug delivery applications.

  2009cited by this paper
• Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.

  2008cited by this paper
• Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.

  2007cited by this paper
• Polymer Architecture and Drug Delivery

  2006cited by this paper
• PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.

  2005cited by this paper
• Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.

  2005cited by this paper
• Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol

  2005influential reference
• Lipophilic 1-β-d-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model

  2005cited by this paper
• Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells.

  2004cited by this paper
• Physical Characterization and Macrophage Cell Uptake of Mannan-Coated Nanoparticles

  2003cited by this paper
• Amphiphilic block copolymers for drug delivery.

  2003cited by this paper
• Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor*

  2002cited by this paper
• Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.

  2002cited by this paper
• Solvent, emulsifier and drug concentration factors in poly(D,L-lactic acid) microspheres containing hexamethylmelamine

  2002cited by this paper
• Pharmaceutics : the science of dosage form design

  2002cited by this paper
• Microparticulate uptake mechanisms of in‐vitro cell culture models of the respiratory epithelium

  2001cited by this paper
• On the importance and mechanisms of burst release in matrix-controlled drug delivery systems.

  2001cited by this paper
• Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.

  2001cited by this paper
• Places of emulsions in drug delivery.

  2000cited by this paper
• Biodegradable PLGA Microspheres Loaded with Ganciclovir for Intraocular Administration. Encapsulation Technique, in Vitro Release Profiles, and Sterilization Process

  2000cited by this paper
• The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.

  2000cited by this paper
• Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.

  2000cited by this paper
• Microemulsion-based media as novel drug delivery systems.

  2000cited by this paper
• Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.

  1999cited by this paper
• Quantitative analysis of polyvinyl alcohol on the surface of poly(D, L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: effect of particle size and PVA concentration.

  1999cited by this paper
• Cellular Uptake Study of Biodegradable Nanoparticles in Vascular Smooth Muscle Cells

  1998cited by this paper
• Influence of the Degrees of Hydrolyzation and Polymerization of Poly(vinylalchol)on the Preparation and Properties of Poly(DL-lactide-co-glycolide)nanoparticle.

  1997cited by this paper
• Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin

  1996cited by this paper
• Microstructural analysis of poly[(l,l-lactide)-co-(glycolide)] by 1H and 13C n.m.r. spectroscopy

  1996cited by this paper
• Dynamic Properties of Poly(DL-lactide) and Polyvinyl Alcohol Monolayers at the Air/Water and Dichloromethane/Water Interfaces

  1995cited by this paper
• The validation of analytical methods for drug substances and drug products in UK pharmaceutical laboratories.

  1994cited by this paper
• Validation of Analytical Methods: A Simple Model for HPLC Assay Methods

  1994cited by this paper
• The preparation and characterisation of poly(lactide-co-glycolide) microparticles. I: Oil-in-water emulsion solvent evaporation

  1991cited by this paper
• Colloidal Carriers for Controlled Drug Delivery and Targeting: Modification, Characterization, and In Vivo Distribution

  1991cited by this paper
• Phagocytosis of polymer microspheres by macrophages

  1990cited by this paper

• NOESY investigation of bicalutamide conformational changes in DMSO: Role of solution concentration in polymorph formation

  2025cites this paper
• Conformational Landscape, Polymorphism, and Solid Forms Design of Bicalutamide: A Review

  2025cites this paper
• Development and optimization of Soluplus®/Pluronic-based polymeric micelles for bicalutamide delivery: characterization, lyophilization, stability, and cellular studies.

  2025cites this paper
• Current developments and future directions in androgen receptor targets using nano-based therapeutics for the management of cancer

  2025cites this paper
• Synergistic induction of apoptosis in lung cancer cells through co-delivery of PLGA phytol/α-bisabolol nanoparticles

  2024cites this paper
• Surface Functionalization of WS2 nanosheets with Poly(N-vinylcaprolactam) and vinylacetic acid for targeted drug release in prostate cancer

  2024cites this paper
• Revolutionizing Cancer Treatment: Exploring the Latest Breakthroughs in Bicalutamide Delivery and Co-Delivery Nanoformulations for Cancer Therapy

  2024cites this paper
• PLGA nanomedical consignation: A novel approach for the management of prostate cancer.

  2024cites this paper
• Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview.

  2023cites this paper
• Formulation, characterization and cellular toxicity assessment of a novel bee-venom microsphere in prostate cancer treatment

  2022cites this paper
• Oral organic nanovaccines against bacterial and viral diseases.

  2022cites this paper
• PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo

  2022cites this paper
• Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins

  2022cites this paper
• A Tri-Stimuli Responsive (Maghemite/PLGA)/Chitosan Nanostructure with Promising Applications in Lung Cancer

  2021cites this paper
• Nanoparticles and prostate cancer

  2021cites this paper
• Chemically-Induced Cross-Linking of Peptidic Fibrils for Scaffolding Polymeric Particles and Macrophages.

  2021cites this paper
• Targeted nanomedicine modalities for prostate cancer treatment.

  2021cites this paper
• Mesoporous silica MCM-41 and HMS as advanced drug delivery carriers for bicalutamide

  2021cites this paper
• Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses

  2021cites this paper
• NIR-Laser Triggered Drug Release from Molybdenum Disulfide Nanosheets Modified with Thermosensitive Polymer for Prostate Cancer Treatment

  2021cites this paper
• Monodispersed magnetographene quantum dot nanocomposites for delivery of silibinin

  2021cites this paper
• Fabrication, characterization and in vitro release kinetics of tofacitinib-encapsulated polymeric nanoparticles: a promising implication in the treatment of rheumatoid arthritis

  2020cites this paper
• Nanomedicines in Drug Delivery from Synthetic and Natural Sources to Their Clinical Applications

  2020cites this paper
• Delivery Of Curcumin Nanoliposomes Using Surface Modi fi ed With CD133 Aptamers For Prostate Cancer

  2019cites this paper
• Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer

  2019cites this paper
• Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses

  2019cites this paper
• Selenium-layered nanoparticles serving for oral delivery of phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect

  2018cites this paper
• Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities

  2018cites this paper
• Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer

  2017cites this paper
• A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of intracellular delivery

  2017cites this paper
• Anti-Proliferative Activity of Curcumin Loaded PLGA Nanoparticles for Prostate Cancer

  2017cites this paper
• Phytol-loaded PLGA nanoparticle as a modulator of Alzheimer’s toxic Aβ peptide aggregation and fibrillation associated with impaired neuronal cell function

  2017cites this paper